CD8A and neoplasm: Previous studies have reported that the prognostic value of tumour-infiltrating lymphocytes (TILs), specifically of CD3+ and/or CD8+ is higher when tumour-infiltrating B lymphocytes (TIL-Bs) and/or plasma cells (PC) are present.